The Law Office of Abe Shainberg Announces an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ZymoG...
13 Setembro 2010 - 4:06PM
Business Wire
The Law Office of Abe Shainberg is investigating the Board of
Directors of ZymoGenetics, Inc. (“ZymoGenetics” or the “Company”)
(NasdaqGM: ZGEN) for possible breaches of fiduciary duty and other
violations of state law in connection with their attempt to sell
the Company to Bristol-Myers Squibb Co. ("Bristol-Myers Squibb")
(NYSE: BMY). Under the terms of the transaction, ZymoGenetics
shareholders will receive $9.75 in cash for each share of
ZymoGenetics common stock they own for a total transaction value of
approximately $885 million.
The investigation concerns whether the ZymoGenetics Board of
Directors breached their fiduciary duties to ZymoGenetics
stockholders by failing to adequately shop the Company before
entering into this transaction and whether Bristol-Meyers Squibb is
underpaying for ZymoGenetics shares, thus unlawfully harming
ZymoGenetics stockholders.
If you own common stock in ZymoGenetics and wish to obtain
additional information, contact Abe Shainberg, Esq. either via
email at as@ashainberglaw.com or by telephone at (212) 425-7286, or
visit http://www.ashainberglaw.com/zymogenetics-zgen.html.
Mr. Shainberg has expertise in prosecuting investor securities
litigation, is a certified and registered arbitrator and mediator
involving financial matters, and represents investors in various
matters nationwide.
Generation Z ETF (NASDAQ:ZGEN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Generation Z ETF (NASDAQ:ZGEN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Generation Z ETF da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de The Law Office of Abe Shainberg